<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The term neurologic symptom usually relates to the loss of motor or sensory functions; <z:e sem="disease" ids="C0679466" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deficit</z:e> is mostly unrecognized in patients with severe <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In large population studies <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> has been shown as independent risk factor for mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (MCI) and it was not due to underlying vascular risk factors </plain></SENT>
<SENT sid="2" pm="."><plain>The term MCI refers to a transitional stage between <z:e sem="disease" ids="C1392786" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive changes</z:e> of <z:mpath ids='MPATH_458'>normal</z:mpath> aging and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>At this stage, <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> is not severe enough to constitute <z:hpo ids='HP_0000726'>dementia</z:hpo>, but also it is beyond the cognitive functioning deficit which is expected in <z:mpath ids='MPATH_458'>normal</z:mpath> aging </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0100546'>Carotid stenosis</z:hpo> detected in population older than 65 is 75% for men and 62% for women, with prevalence of stenosis â‰¥ 50% in this population 7% for men and 5% for women </plain></SENT>
<SENT sid="5" pm="."><plain>There are two possible underlying pathomorphological mechanisms of <z:e sem="disease" ids="C1392786" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive changes</z:e> in patients with <z:e sem="disease" ids="C0741975" disease_type="Disease or Syndrome" abbrv="">carotid disease</z:e> - <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral emboli</z:e> and hypoperfusion with or without silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In both cases loss of regional cerebral autoregulation can be recognized by means of neurosonology (transcranial Doppler ultrasonography) </plain></SENT>
<SENT sid="7" pm="."><plain>Most of the studies which evaluated cognitive functions before and after CEA/CAS have shown improvement or no changes in cognitive functions, but no deteriorations </plain></SENT>
<SENT sid="8" pm="."><plain>There are still no clear recommendations about using CEA/CAS in treating <z:e sem="disease" ids="C0679466" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deficit</z:e> in otherwise asymptomatic patients </plain></SENT>
<SENT sid="9" pm="."><plain>It is important to recognize <z:e sem="disease" ids="C1392786" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive changes</z:e> as a symptom of <z:e sem="disease" ids="C0741975" disease_type="Disease or Syndrome" abbrv="">carotid disease</z:e> in order to follow up such patients and include <z:e sem="disease" ids="C0679466" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deficit</z:e> as one of the criteria in calculating perioperative risk and benefit from CEA/CAS </plain></SENT>
</text></document>